Journal: Scientific Reports
Article Title: Acid-sensing ion channel 3 is a new potential therapeutic target for the control of glioblastoma cancer stem cells growth
doi: 10.1038/s41598-024-71623-9
Figure Lengend Snippet: The ASIC3 isoform is enriched in glioblastoma CSCs. ( a ) Western blot analysis of ASIC3 and ASIC1a expression in human primary GBM-CSC lines from the three GBM subtypes ( PN proneural, MES mesenchymal, CL classical). ASIC3 (n ≥ 3) ( b ) and ASIC1a (n = 3) ( b ’) protein expression quantification normalized on actin levels in the different GBM-CSC lines. ( c ) Western Blot analysis of CD133/prominin1 and ASIC3 expression in a healthy human brain lysate, in the GBM-MES CSCs 0315 line and in a biopsy from the same patient used to generate the CSC line 0315. ( c ’) ASIC3 and CD133/prominin1 protein expression quantification normalized for actin levels, in healthy human brain, GBM MES 0315 line and MES 0315 patient’s biopsy (n = 4). Statistic was performed by a two-way Anova with Bonferroni’s post-test:(****) p < 0,0001. ( d ) Data from publically available Repository for Molecular BRAIN Neoplasia Data (TCGA datasets Affymetrix HT HG U133A) were used to determine the relative expression of ASIC3 mRNA (ACCN3) in four human glioma subtypes (Classical, Mesenchymal, Neuronal, and Proneuronal), as well as in healthy patients. All 454 glioma patients with available mRNA were examined. ( e ) Western Blot analysis of ASIC3 expression in GBM-CSCs MES 0315 growth in 3D and 2D culture conditions after 24hin culture. Original blots were horizontally cropped at the appropriate MW region in order to perform multiple staining on the same blot. In the figure, portions of the same blot are separated by white lines. Black lines are used to separate independent blots presented in the same figure. Original blots are shown in supplementary figure S1 and S4. Dots represent independent experiments. Measurements were taken from distinct samples. Graphs for ( b,b’,c’ ) were analyzed with GraphPad Prism 9, graph for ( d ) was obtained from https://www.betastasis.com/glioma/tcga_gbm/ .
Article Snippet: The coverslips were incubated with either an anti-human ASIC3 (1:500, Cat: ASC-018; Alomone Labs, Jerusalem, Israel), an anti-human CD133 (1:800, Cat: D4 W4N; Cell Signaling Technology, Denvers, MA, USA) or an anti-human Ki67 (1:250, Cat: ab16667, Abcam, Cambridge, UK) primary antibody overnight at 4 °C.
Techniques: Western Blot, Expressing, Staining